Solventum Co. (NYSE:SOLV) Receives Average Recommendation of “Hold” from Brokerages

Shares of Solventum Co. (NYSE:SOLV) have been given a consensus rating of “Hold” by the eleven brokerages that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $68.29.

A number of analysts have recently commented on SOLV shares. Stifel Nicolaus started coverage on Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target on the stock. Piper Sandler boosted their price target on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. Mizuho began coverage on Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target on the stock. Finally, Morgan Stanley lifted their target price on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th.

Institutional Investors Weigh In On Solventum

Institutional investors have recently made changes to their positions in the stock. Modus Advisors LLC bought a new position in shares of Solventum in the 4th quarter valued at $25,000. Copeland Capital Management LLC acquired a new stake in Solventum in the third quarter valued at $26,000. Stonebridge Financial Group LLC acquired a new stake in Solventum during the 4th quarter worth about $26,000. Mather Group LLC. acquired a new stake in Solventum during the 3rd quarter worth about $27,000. Finally, Crews Bank & Trust acquired a new stake in Solventum during the 4th quarter worth about $32,000.

Solventum Stock Down 0.7 %

NYSE SOLV opened at $73.57 on Tuesday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum has a 52 week low of $47.16 and a 52 week high of $96.05. The stock has a fifty day moving average of $70.17 and a 200-day moving average of $67.43.

Solventum (NYSE:SOLV) last posted its earnings results on Thursday, November 7th. The company reported $1.15 earnings per share for the quarter, missing the consensus estimate of $1.38 by ($0.23). The business had revenue of $2.08 billion during the quarter, compared to analysts’ expectations of $2.05 billion. Analysts forecast that Solventum will post 6.58 EPS for the current year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.